Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

We evaluated the prognostic relevance of several clinical and laboratory parameters in 226 Mayo Clinic patients with chronic myelomonocytic leukemia (CMML): 152 (67%) males and median age 71 years. At a median follow-up of 15 months, 166 (73%) deaths and 33 (14.5%) leukemic transformations were docu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia 2013-07, Vol.27 (7), p.1504-1510
Hauptverfasser: Patnaik, M M, Padron, E, LaBorde, R R, Lasho, T L, Finke, C M, Hanson, C A, Hodnefield, J M, Knudson, R A, Ketterling, R P, Al-kali, A, Pardanani, A, Ali, N A, Komroji, R S, Tefferi, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!